![Paul Herrling](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paul Herrling
Direktor/Vorstandsmitglied bei University of Basel
Profil
Paul Linus Herrling is currently a Trustee at The Scripps Research Institute, a Trustee at the University of Basel, a Vice President at the Swiss Federal Institute of Technology, and a Trustee at the Foundation for the National Institutes of Health, Inc. In the past, Dr. Herrling served as the Chairman at Novartis Institute for Tropical Diseases Pte Ltd., Director at Chiron Corp., Director at Novartis Institute for Functional Genomics, Inc., Director at Novartis International Pharmaceutical Ltd., and Head-Corporate Research at Novartis International AG.
He was also the Head-Corporate Research at Novartis AG, an Independent Member-Supervisory Board at Evotec SE, Head-Corporate Research at Sandoz AG, Head-Novartis Institutes at Novartis Institutes for Biomedical Research, Inc., and Head-Global Research at Novartis Pharma AG.
Additionally, he served as a Vice President at ETH-Rat from 2008 to 2018.
Dr. Herrling obtained a doctorate degree from the University of Zurich in 1975 and a graduate degree from the same university in 1971.
Aktuelle Nachrichten zu Paul Herrling
Aktive Positionen von Paul Herrling
| Unternehmen | Position | Beginn |
|---|---|---|
| University of Basel | Direktor/Vorstandsmitglied | 03.09.2010 |
The Scripps Research Institute
 The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | Direktor/Vorstandsmitglied | 03.09.2010 |
| Swiss Federal Institute of Technology | Corporate Officer/Principal | 03.09.2010 |
Foundation for the National Institutes of Health, Inc.
 Foundation for the National Institutes of Health, Inc. Miscellaneous Commercial ServicesCommercial Services Foundation for the National Institutes of Health, Inc. provides healthcare services. It offers services to public health through scientific discovery, translational research and dissemination of research results through public-private partnerships. The organization was founded in 1996 and is headquartered in Bethesda, MD | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Paul Herrling
| Unternehmen | Position | Ende |
|---|---|---|
| ETH-Rat | Corporate Officer/Principal | 01.01.2018 |
| EVOTEC SE | Direktor/Vorstandsmitglied | 14.06.2017 |
Novartis International Pharmaceutical Ltd.
 Novartis International Pharmaceutical Ltd. Pharmaceuticals: MajorHealth Technology Novartis International Pharmaceutical Ltd. manufactures and distributes pharmaceutical products. The company is headquartered in Ireland. | Direktor/Vorstandsmitglied | 01.11.2016 |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01.12.2011 |
Novartis International AG
 Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2010 |
Ausbildung von Paul Herrling
| University of Zurich | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| NOVARTIS AG | Health Technology |
| EVOTEC SE | Health Technology |
| Private Unternehmen | 10 |
|---|---|
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |
Sandoz AG
 Sandoz AG Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz AG is a leader in generic and biosimilar medicines. The company is based in Basel, Switzerland. Sandoz traces its heritage back to 1886 and has a history of breakthroughs, including the world's first oral penicillin in 1951 and the world's first biosimilar in 2006. With a sales achievement of USD 9.1 billion in 2022 and a portfolio of approximately 1,500 products, Sandoz provides 800 million patient treatments annually, addressing diseases from the common cold to cancer. Richard Saynor has been the CEO of the Swiss company since 2019. | Health Technology |
Novartis Institute for Tropical Diseases Pte Ltd.
 Novartis Institute for Tropical Diseases Pte Ltd. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Institute for Tropical Diseases Pte Ltd. is a Singaporean company that develops novel small molecule therapies for tropical infectious diseases. The company is based in Singapore, Singapore. | Health Technology |
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Health Technology |
Foundation for the National Institutes of Health, Inc.
Foundation for the National Institutes of Health, Inc. Miscellaneous Commercial ServicesCommercial Services Foundation for the National Institutes of Health, Inc. provides healthcare services. It offers services to public health through scientific discovery, translational research and dissemination of research results through public-private partnerships. The organization was founded in 1996 and is headquartered in Bethesda, MD | Commercial Services |
Novartis International Pharmaceutical Ltd.
Novartis International Pharmaceutical Ltd. Pharmaceuticals: MajorHealth Technology Novartis International Pharmaceutical Ltd. manufactures and distributes pharmaceutical products. The company is headquartered in Ireland. | Health Technology |
| ETH-Rat | |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Commercial Services |
Novartis International AG
Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland. | Health Technology |
Novartis Institute for Functional Genomics, Inc.
 Novartis Institute for Functional Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institute For Functional Genomics, Inc. serves as a bridge between basic science and preclinical drug discovery for Novartis’ global research organization. Its focus areas include oncology, autoimmunity, cardiovascular disease, diabetes, musculoskeletal disorders, and infectious disease. The company was founded in 1999 and is headquartered in San Diego, CA. | Commercial Services |
